Singapore /MyNewsDesk/ —Novus Scientific today announces that TIGR® Matrix distribution agreements have been signed with partners in France, Italy (including the Vatican and San Marino), Spain, the United Kingdom (including Northern Ireland) and Switzerland. Direct sales have begun in Sweden, while suitable partners are being sought in other European countries.
Steve Chaplin, Managing Director of Pulse Surgical Ltd in the United Kingdom said: “Pulse Surgical are delighted to be working with Novus within the UK market, where their products should perfectly complement our existing focus on promoting innovative, quality devices in the surgical arena for enhanced clinical outcomes and cost benefits to the healthcare providers.”
Covering the Italian market, AMS s.a (Advanced Medical Supplies) Managing Director Sergio Marazzi said: ”The people of AMS are looking forward to a successful collaboration with Novus Scientific and to being able to present TIGR® Matrix Surgical Mesh to Italian surgeons. This innovative product fits perfectly into our portfolio and strengthens our pledge of bringing excellent patient care products to our customers.”
TIGR® Matrix Surgical Mesh is the world’s 1st long-term resorbable,100% absorbable synthetic mesh indicated for reinforcement of soft tissue where weakness exists. Its unique patented dual-fiber construction is designed for gradually increasing mechanical compliance, making it strong for 6 months and gone in 3 years. The US Food and Drug Administration (FDA) gave the company 510(k) clearance to market TIGR® Matrix Surgical Mesh In January 2010. In August 2011 Novus Scientific received CE Mark approval from BSI for TIGR® Matrix Surgical Mesh in Europe.
About Novus Scientific
Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of absorbable synthetic medical devices.
TIGR® is a trademark of Novus Scientific Pte. Ltd
CONTACT: Tom Haeleydt – Responsible for Business Development – EMEA
· Email Tom Haeleydt (tom.haeleydt@novusscientific.com)
Visit our PRESSROOM: http://www.mynewsdesk.com/pressroom/novus-scientific
